Misoprostol Clinical Trial
Official title:
Misoprostol With And Without Transcervical Balloon Catheter In Second Trimester Termination Of Pregnancy: A Randomized Controlled Trial
This randomized controlled study will be performed to compare the benefits and risks associated with the administration of misoprostol with or without the use of a transcervical balloon catheter to terminate pregnancy in the second trimester (defined as gestational age between 14 and 28 weeks of gestation).
Status | Recruiting |
Enrollment | 108 |
Est. completion date | July 31, 2017 |
Est. primary completion date | June 30, 2017 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: pregnancy in the second trimester (defined as gestational age between
14 and 28 weeks of gestation) with a medical indication for termination of pregnancy. Exclusion Criteria: |
Country | Name | City | State |
---|---|---|---|
Egypt | Ain Shams University Maternity Hospital | Cairo Governorate | Cairo |
Lead Sponsor | Collaborator |
---|---|
Ain Shams Maternity Hospital |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Induction-expulsion interval | The duration from the administration of the first misoprostol dose vaginally till complete expulsion of the uterine contents; complete uterine emptiness will be confirmed by ultrasonographic assessment | 48 hours from starting intervention | |
Secondary | Total required doses of misoprostol | The total amount of misoprostol used per participant during the procedure | 48 hours from starting induction | |
Secondary | The need for surgical interventions | The number of participants requiring any surgical intervention under anesthesia to complete uterine emptiness | 1 week from starting induction |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04604366 -
Comparison of Vaginal Versus Sublingual Misoprostol in the Treatment of First Trimester Missed Miscarriage
|
Phase 2 | |
Completed |
NCT03727308 -
Study of Clinic-based Versus Self-use of Medical Abortion Pills
|
||
Completed |
NCT00426491 -
Misoprostol for Non-Viable Pregnancies
|
Phase 3 | |
Not yet recruiting |
NCT05343546 -
Ideal Timing of Intrauterine Contraception Insertion After Medical Management of First Trimester Incomplete Abortion
|
N/A | |
Recruiting |
NCT01636063 -
Mifepristone Versus Misoprostol for Cervical Preparation Prior to Surgical Abortion Between 11 to 15 Weeks
|
N/A | |
Not yet recruiting |
NCT05696574 -
Oral and Vaginal Misoprostol for Induction of Labor in Nulliparous Pregnant Women
|
N/A | |
Completed |
NCT04635007 -
Tranexamic Acid Versus Misoprostol in Reducing Blood Loss in Cesarean Section in Primigravida
|
Phase 3 | |
Withdrawn |
NCT03140384 -
Compare the Different Routes of Administration of Misoprostol During Medicinal Abortion Between 7 and 9 Weeks of Amenorrhoea (SA)
|
Phase 3 | |
Completed |
NCT04492072 -
Misoprostol With Mechanical Dilation Versus Oxytocin With Mechanical Dilation for High-risk Pregnancy Inductions
|
N/A | |
Not yet recruiting |
NCT05079061 -
A Trial of Sublingual Misoprostol to Reduce Primary Postpartum Haemorrhage After Vaginal Delivery
|
Phase 4 |